1.61

6.62% 0.10

Standard Biotools Inc (LAB)

Overview News Price History Option Chain Financials Discussions Forecast

Standard Biotools Inc stock is traded at $1.61, with a volume of 3.14M. It is up +6.62% in the last 24 hours and down -15.26% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Previous Close:

$1.51

Open:

$1.51

24h Volume:

3.14M

Relative Volume:

1.67

Market Cap:

$599.34M

Revenue:

$106.34M

Net Income/Loss:

$-74.66M

P/E Ratio:

-1.5189

EPS:

-1.06

Net Cash Flow:

$-46.12M

1W Performance:

-12.50%

1M Performance:

-15.26%

6M Performance:

-37.60%

1Y Performance:

-29.07%

1-Day Range:

$1.475

$1.69

1-Week Range:

$1.46

$1.84

52-Week Range:

$1.21

$3.04

Standard Biotools Inc Stock (LAB) Company Profile

Name

Standard Biotools Inc

Sector

Healthcare (1193)

Industry

Medical Devices (152)

Phone

(650) 266-6000

Address

2 TOWER PLACE, SOUTH SAN FRANCISCO

Employee

539

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LAB's Discussions on Twitter

Compare LAB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LAB	1.61	599.34M	106.34M	-74.66M	-46.12M	-1.06
ABT	115.93	201.34B	41.22B	5.77B	6.49B	2.94
SYK	385.68	146.32B	21.97B	3.59B	3.21B	6.74
BSX	90.17	132.22B	15.91B	1.79B	1.89B	0.82
MDT	84.11	107.39B	33.00B	4.29B	5.50B	2.71
EW	69.54	41.01B	6.60B	4.16B	490.10M	2.34

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Stock (LAB) Latest News

Nov 18, 2024

Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Nov 18, 2024

Nov 14, 2024

Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com

Nov 14, 2024

Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World

Nov 14, 2024

Nov 08, 2024

Standard BioTools names new CFO By Investing.com - Investing.com Australia

Nov 08, 2024

ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Nov 08, 2024

Nov 07, 2024

Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com

Nov 07, 2024

Standard BioTools Names Co-Founder Alex Kim as CFO, Brings 30-Year Industry Expertise | LAB Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 - StreetInsider.com

Nov 06, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com

Nov 05, 2024

Nov 02, 2024

Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance

Nov 02, 2024

Nov 01, 2024

TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia

Nov 01, 2024

Standard BioTools Q3 2024 Earnings Preview - MSN

Nov 01, 2024

Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 01, 2024

Oct 31, 2024

Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia

Oct 31, 2024